Saffron Walden, United Kingdom

Andrew Sharpe

This inventor holds 30 USPTO granted patents and 2 published patent applications and 11 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Darwin Discovery Limited, Ucb Pharma, S.a., Kabushiki Kaisha Toshiba. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Sharpe. Retrieved from https://idiyas.com/inventor/andrew-sharpe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 30 

% Patents Active = 60.0

 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 164(Granted Patents)


Location History:

  • Slough, GB (2012)
  • Saffron Walden Essex, GB (2014 - 2019)
  • Saffron Walden, GB (1996 - 2020)
  • Cambridge, GB (2000 - 2021)

Company Filing History:


Years Active: 1996-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Cannabinoid Derivatives
NADPH Oxidase Inhibitors
Kinase Inhibitors
Heterocyclic Compounds
Chemical Compounds
Quantum Communication
Single Photon Detectors
Breathing Apparatus
Amido Thiadiazole Derivatives
Pyrazol Compounds
Benzothiazole Compounds
Therapeutic Use
30 patents (USPTO):Explore Patents

Title: Andrew Sharpe: Innovating in Photon Detection and Chemical Compounds

Introduction: Andrew Sharpe, a prolific inventor based in Saffron Walden, GB, has made significant contributions to the fields of photon detection devices and chemical compounds. With an impressive portfolio of 28 patents, his work has been instrumental in advancing technology and scientific research.

Latest Patents:

1. In his latest patent, Andrew Sharpe introduced the concept of on-chip integration of MMIC and single photon detectors, revolutionizing photon detection devices. This innovation involves a method of fabricating a photon detection device that combines AC and DC input voltages to detect single photons with exceptional precision.

2. Another notable patent by Andrew Sharpe focuses on chemical compounds that inhibit kinase activity, particularly PI3-kinase activity. These novel compounds, represented by formula (I) and its salts, have shown promising potential in the field of medical research and drug development.

Career Highlights:

Throughout his career, Andrew Sharpe has showcased a remarkable talent for innovation and problem-solving. His patents reflect a deep understanding of complex technologies and a dedication to pushing the boundaries of scientific discovery. Sharpe has not only secured patents but has also actively contributed to the practical application of his inventions.

Collaborations:

Andrew Sharpe has collaborated with esteemed professionals in his field, including Alan Findlay Haughan and Hazel Joan Dyke. Together, they have leveraged their expertise to develop cutting-edge solutions and drive forward advancements in photon detection and chemical compound research.

Conclusion:

In conclusion, Andrew Sharpe stands out as a visionary inventor whose work has left a lasting impact on the fields of photon detection and chemical compounds. His innovative spirit, coupled with a strong scientific acumen, continues to drive progress and inspire future generations of inventors in the ever-evolving landscape of technology and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…